Phase 2 protein inducers in the diet promote healthier aging

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 63, Issue 11, 2008, Pages 1168-1176

  Noyan Ashraf, Mohammad Hossein ^a   Sadeghinejad, Zahra ^a   Davies, Gerald F ^a   Ross, Andrew R ^c   Saucier, Deborah ^b   Harkness, Troy A A ^a   Juurlink, Bernhard H J ^a,d  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

^c NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^d ALFAISAL UNIVERSITY   (Saudi Arabia)

Author keywords

Antioxidant response; Diet; Healthy aging; Inflammation; Oxidative stress

Indexed keywords

BUTYLATED HYDROXYANISOLE; CCAAT ENHANCER BINDING PROTEIN ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

AGING; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; C57BL 6 MOUSE; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; FOOD INTAKE; GENE EXPRESSION; INFLAMMATION; LIVER; LOCOMOTION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; WEIGHT GAIN;

MUS;

EID: 57149090981     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/63.11.1168     Document Type: Article

References (71)

1. Chung HY, Sung B, Jung KJ, Zou Y, Yu BP. The molecular inflammatory process in aging. Antioxid Redox Signal. 2006;8:572-581.
2. Ershler WB. A gripping reality: oxidative stress, inflammation, and the pathway to frailty. J Appl Physiol. 2007;103:3-5.
3. Franceschi C. Inflammaging as a major characteristic of old people: can it be prevented or cured? Nutr Rev. 2007;65:S173-S176.
4. Vasto S, Candore G, Balistreri CR, et al. Inflammatory networks in ageing, age-related diseases and longevity. Mech Ageing Dev. 2007;128:83-91.
5. Mendoza-Nunez VM, Ruiz-Ramos M, Sanchez-Rodriguez MA, Retana-Ugalde R, Munoz-Sanchez JL. Aging-related oxidative stress in healthy humans. Tohoku J Exp Med. 2007;213:261-268.
6. Dayhoff-Brannigan M, Ferrucci L, Sun K, et al. Oxidative protein damage is associated with elevated serum interleukin-6 levels among older moderately to severely disabled women living in the community. J Gerontol A Biol Sci Med Sci. 2008;63:179-183.
7. Junqueira VB, Barros SB, Chan SS, et al. Aging and oxidative stress. Mol Aspects Med. 2004;25:5-16.
8. Finkel T, Holbrook NJ. Oxidants, oxidative stress and the biology of ageing. Nature. 2000;408:239-247.
9. Juurlink BHJ. Management of oxidative stress in the CNS: the many roles of glutathione. Neurotox Res. 1999;1:119-140.
10. Samiec PS, Drews-Botsch C, Flagg EW, et al. Glutathione in human plasma: decline in association with aging, age-related macular degeneration, and diabetes. Free Radic Biol Med. 1998;24:699-704.
11. Erden-Inal M, Sunal E, Kanbak G. Age-related changes in the glutathione redox system. Cell Biochem Funct. 2002;20:61-66.
12. Rebrin I, Kamzalov S, Sohal RS. Effects of age and caloric restriction on glutathione redox state in mice. Free Radic Biol Med. 2003;35:626-635.
13. Armeni T, Pieri C, Marra M, Saccucci F, Principato G. Studies on the life prolonging effect of food restriction: glutathione levels and glyoxalase enzymes in rat liver. Mech Ageing Dev. 1998;101:101-110.
14. Cao SX, Dhahbi JM, Mote PL, Spindler SR. Genomic profiling of short- and long-term caloric restriction effects in the liver of aging mice. Proc Natl Acad Sci U S A. 2001;98:10630-10635.
15. Kalani R, Judge S, Carter C, Pahor M, Leeuwenburgh C. Effects of caloric restriction and exercise on age-related, chronic inflammation assessed by C-reactive protein and interleukin-6. J Gerontol A Biol Sci Med Sci. 2006;61:211-217.
16. Morgan TE, Wong AM, Finch CE. Anti-inflammatory mechanisms of dietary restriction in slowing aging processes. Interdiscip Top Gerontol. 2007;35:83-97.
17. Heilbronn LK, Ravussin E. Calorie restriction and aging: review of the literature and implications for studies in humans. Am J Clin Nutr. 2003;78:361-369.
18. Holloszy JO, Fontana L. Caloric restriction in humans. Exp Gerontol. 2007;42:709-712.
19. Juurlink BHJ. Therapeutic potential of dietary phase 2 enzyme inducers in ameliorating diseases that have an underlying inflammatory component. Can J Physiol Pharmacol. 2001;79:266-282.
20. Juurlink BHJ. Dietary phase 2 protein inducers and atherosclerosis. International Atherosclerosis Society Commentaries. 2004. Available under Juurlink in the Archived Commentaries at: http://www.athero.org/comm-index3b.asp
21. Thimmulappa RK, Mai KH, Srisuma S, Kensler TW, Yamamoto M, Biswal S. Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray. Cancer Res. 2002;62:5196-5203.
22. Lyakhovich VV, Vavilin VA, Zenkov NK, Menshchikova EB. Active defense under oxidative stress. The antioxidant responsive element. Biochemistry (Mosc). 2006;71:962-974.
23. Dinkova-Kostova AT, Liby KT, Stephenson KK, et al. Extremely potent triterpenoid inducers of the phase 2 response: correlations of protection against oxidant and inflammatory stress. Proc Natl Acad Sci U S A. 2005;102:4584-4589.
24. Talalay P, Dinkova-Kostova AT, Holtzclaw WD. Importance of phase 2 gene regulation in protection against electrophile and reactive oxygen toxicity and carcinogenesis. Adv Enzyme Regul. 2003;43:121-134.
25. Talalay P, Fahey JW, Holtzclaw WD, Prestera T, Zhang Y. Chemoprotection against cancer by phase 2 enzyme induction. Toxicol Lett. 1995;82-83:173-179.
26. Suh JH, Shenvi SV, Dixon BM, et al. Decline in transcriptional activity of Nrf2 causes age-related loss of glutathione synthesis, which is reversible with lipoic acid. Proc Natl Acad Sci U S A. 2004;101:3381-3386.
27. Shih PH, Yen GC. Differential expressions of antioxidant status in aging rats: the role of transcriptional factor Nrf2 and MAPK signaling pathway. Biogerontology. 2007;8:71-80.
28. Noyan-Ashraf MH, Wu L, Wang R, Juurlink BHJ. Dietary approaches to positively influence fetal determinants of adult health. FASEB J. 2006;20:371-373.
29. Wu L, Noyan-Ashraf MH, Facci M, et al. Dietary approach to attenuate oxidative stress, hypertension, and inflammation in the cardiovascular system. Proc Natl Acad Sci U S A. 2004;101:7094-7099.
30. Noyan-Ashraf MH, Sadeghinejad Z, Juurlink BHJ. Dietary approach to decrease aging-related CNS inflammation. Nutr Neurosci. 2005;8:101-110.
31. Noyan-Ashraf MH, Wu L, Wang R, Juurlink BH. Dietary approaches to positively influence fetal determinants of adult health. FASEB J. 2006;20:371-373.
32. Benson AM, Hunkeler MJ, Talalay P. Increase of NAD(P)H:quinone reductase by dietary antioxidants: possible role in protection against carcinogenesis and toxicity. Proc Natl Acad Sci U S A. 1980;77:5216-5220.
33. De Long MJ, Prochaska HJ, Talalay P. Tissue-specific induction patterns of cancer-protective enzymes in mice by tert-butyl-4-hydroxyanisole and related substituted phenols. Cancer Res. 1985;45:546-551.
34. Nair S, Xu C, Shen G, et al. Pharmacogenomics of phenolic antioxidant butylated hydroxyanisole (BHA) in the small intestine and liver of Nrf2 knockout and C57BL/6J mice. Pharm Res. 2006;23:2621-2637.
35. Lawson T, Stohs S. Changes in endogenous DNA damage in aging mice in response to butylated hydroxyanisole and oltipraz. Mech Ageing Dev. 1985;30:179-185.
36. Ross AR, Lee PJ, Smith DL, Langridge JI, Whetton AD, Gaskell SJ. Identification of proteins from two-dimensional polyacrylamide gels using a novel acid-labile surfactant. Proteomics. 2002;2:928-936.
37. Modo M, Stroemer RP, Tang E, Veizovic T, Sowniski P, Hodges H. Neurological sequelae and long-term behavioural assessment of rats with transient middle cerebral artery occlusion. J Neurosci Methods. 2000;104:99-109.
38. McLellan LI, Hayes JD. Differential induction of class alpha glutathione S-transferases in mouse liver by the anticarcinogenic antioxidant butylated hydroxyanisole. Purification and characterization of glutathione S-transferase Ya1Ya1. Biochem J. 1989;263:393-402.
39. Chanas SA, Jiang Q, McMahon M, et al. Loss of the Nrf2 transcription factor causes a marked reduction in constitutive and inducible expression of the glutathione S-transferase Gsta1, Gsta2, Gstm1, Gstm2, Gstm3 and Gstm4 genes in the livers of male and female mice. Biochem J. 2002;365:405-416.
40. Yoo HY, Chang MS, Rho HM. The activation of the rat copper/zinc superoxide dismutase gene by hydrogen peroxide through the hydrogen peroxide-responsive element and by paraquat and heat shock through the same heat shock element. J Biol Chem. 1999;274:23887-23892.
41. Christman JW, Blackwell TS, Juurlink BHJ. Redox regulation of nuclear factor kappa B: therapeutic potential for attenuating inflammatory responses. Brain Pathol. 2000;10:153-162.
42. Radak Z, Chung HY, Naito H, et al. Age-associated increase in oxidative stress and nuclear factor kappaB activation are attenuated in rat liver by regular exercise. FASEB J. 2004;18:749-750.
43. Hinton DE, Williams WL. Hepatic fibrosis associated with aging in four stocks of mice. J Gerontol. 1968;23:205-211.
44. Leung PS, Suen PM, Ip SP, Yip CK, Chen G, Lai PB. Expression and localization of AT1 receptors in hepatic Kupffer cells: its potential role in regulating a fibrogenic response. Regul Pept. 2003;116:61-69.
45. Hisaka T, Desmouliere A, Taupin JL, et al. Expression of leukemia inhibitory factor (LIF) and its receptor gp190 in human liver and in cultured human liver myofibroblasts. Cloning of new isoforms of LIF mRNA. Comp Hepatol. 2004;3:10.
46. Wallace JE, Krauter EE, Campbell BA. Motor and reflexive behavior in the aging rat. J Gerontol. 1980;35:364-370.
47. Baloh RW, Ying SH, Jacobson KM. A longitudinal study of gait and balance dysfunction in normal older people. Arch Neurol. 2003;60:835-839.
48. Kullberg S, Aldskogius H, Ulfhake B. Microglial activation, emergence of ED1-expressing cells and clusterin upregulation in the aging rat CNS, with special reference to the spinal cord. Brain Res. 2001;899:169-186.
49. Penninx BW, Kritchevsky SB, Newman AB, et al. Inflammatory markers and incident mobility limitation in the elderly. J Am Geriatr Soc. 2004;52:1105-1113.
50. Zaman MB, Leonard MO, Ryan EJ, et al. Lower expression of Nrf2 mRNA in older donor livers: a possible contributor to increased ischemia-reperfusion injury? Transplantation. 2007;84:1272-1278.
51. Kwak MK, Itoh K, Yamamoto M, Kensler TW. Enhanced expression of the transcription factor Nrf2 by cancer chemopreventive agents: role of antioxidant response element-like sequences in the nrf2 promoter. Mol Cell Biol. 2002;22:2883-2892.
52. Hu R, Xu C, Shen G, et al. Gene expression profiles induced by cancer chemopreventive isothiocyanate sulforaphane in the liver of C57BL/6J mice and C57BL/6J/Nrf2 (-/-) mice. Cancer Lett. 2006;243:170-192.
53. Chaubey M, Singhal SS, Awasthi S, et al. Gender-related differences in expression of murine glutathione S-transferases and their induction by butylated hydroxyanisole. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol. 1994;108:311-319.
54. Parola M, Robino G. Oxidative stress-related molecules and liver fibrosis. J Hepatol. 2001;35:297-306.
55. Lee CK, Weindruch R, Prolla TA. Gene-expression profile of the ageing brain in mice. Nat Genet. 2000;25:294-297.
56. van Buul JD, Kanters E, Hordijk PL. Endothelial signaling by Ig-like cell adhesion molecules. Arterioscler Thromb Vasc Biol. 2007;27:1870-1876.
57. Sykiotis GP, Bohmann D. Keap1/Nrf2 signaling regulates oxidative stress tolerance and lifespan in Drosophila. Dev Cell. 2008;14:76-85.
58. Tullet JM, Hertweck M, An JH, et al. Direct inhibition of the longevity-promoting factor SKN-1 by insulin-like signaling in C. elegans. Cell. 2008;132:1025-1038.
59. Tanaka Y, Aleksunes LM, Yeager RL, et al. Nf-E2-related factor 2 (Nrf2) inhibits lipid accumulation and oxidative stress in mice fed a high-fat diet. J Pharmacol Exp Ther. 2008;325:655-664. Epub 2008 Feb 15.
60. Kwak MK, Wakabayashi N, Itoh K, Motohashi H, Yamamoto M, Kensler TW. Modulation of gene expression by cancer chemopreventive dithiolethiones through the Keap1-Nrf2 pathway. Identification of novel gene clusters for cell survival. J Biol Chem. 2003;278:8135-8145.
61. Shimano H. Sterol regulatory element-binding protein family as global regulators of lipid synthetic genes in energy metabolism. Vitam Horm. 2002;65:167-194.
62. Couillard C, Ruel G, Archer WR, et al. Circulating levels of oxidative stress markers and endothelial adhesion molecules in men with abdominal obesity. J Clin Endocrinol Metab. 2005;90:6454-6459.
63. Colbert LH, Visser M, Simonsick EM, et al. Physical activity, exercise, and inflammatory markers in older adults: findings from the Health, Aging and Body Composition Study. J Am Geriatr Soc. 2004;52:1098-1104.
64. Suzuki K, Ito Y, Ochiai J, et al. Relationship between obesity and serum markers of oxidative stress and inflammation in Japanese. Asian Pac J Cancer Prev. 2003;4:259-266.
65. Stienstra R, Duval C, Müller M, Kersten S. PPARs, obesity, and inflammation. PPAR Res. 2007;2007:95974.
66. Gavrilova O, Haluzik M, Matsusue K, et al. Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass. J Biol Chem. 2003;278:34268-34276.
67. Ye P, Zhang XJ, Wang ZJ, Zhang C. Effect of aging on the expression of peroxisome proliferator-activated receptor gamma and the possible relation to insulin resistance. Gerontology. 2006;52:69-75.
68. Diep QN, Amiri F, Benkirane K, Paradis P, Schiffrin EL. Long-term effects of the PPAR gamma activator pioglitazone on cardiac inflammation in stroke-prone spontaneously hypertensive rats. Can J Physiol Pharmacol. 2004;82:976-985.
69. Yang L, Chan CC, Kwon OS, et al. Regulation of peroxisome proliferator-activated receptor {gamma} (PPAR{gamma}) in liver fibrosis. Am J Physiol Gastrointest Liver Physiol. 2006;291:G902-G911.
70. Roesler WJ. The role of C/EBP in nutrient and hormonal regulation of gene expression. Annu Rev Nutr. 2001;21:141-165.
71. Qiao L, Maclean PS, You H, Schaack J, Shao J. Knocking down liver C/EBP{alpha} by adenovirus-transduced siRNA improves hepatic gluconeogenesis and lipid homeostasis in db/db mice. Endocrinology. 2006;147:3060-3069.